Microbiome and Metabolome Profiles in Couples Undergoing IVF and Reproductive Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-40
SponsorKarolinska Institutet

About this trial

This prospective observational cohort study investigates the role of the microbiome and metabolome in couples undergoing in vitro fertilization. Biological samples will be collected from both female and male partners, including semen, vaginal, and blood samples, to characterize microbial composition and metabolic profiles. The study aims to examine how these biological profiles are associated with reproductive outcomes such as fertilization, pregnancy, miscarriage, and live birth. Participants will be followed longitudinally, and reproductive and obstetric outcomes will be obtained through linkage with national health registers.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Women aged 18 to 40 years at enrolment.

Men aged between 18 to 56 years at enrolment.

Couples planning to undergo IVF treatment at a participating centre.

Sufficient understanding of spoken and written Swedish or English to provide informed consent and complete the web-based questionnaire.

Disqualifiers

Pregnancy at the time of enrolment (confirmed or suspected).

Recent systemic antibiotic use within the past 4 weeks

Active vaginal or genital tract infection at the time of sampling

Trial population

Couples undergoing in vitro fertilization (IVF) treatment at participating fertility clinics in Sweden. Eligible couples are consecutively recruited at the time of IVF treatment initiation and followed prospectively for reproductive outcomes through linkage with national health registers.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group
Group A: Couples Undergoing IVF Treatment

Trial outcomes

Primary outcomes

1

Number of Participants with Live Birth

Delivery of a live-born infant after IVF treatment, identified through linkage with national health registers.

Time frame
Through delivery, up to 12 months after embryo transfer

Secondary outcomes

1

Number of Participants With Miscarriage Before 22 Weeks of Gestation

Pregnancy loss before 22 weeks of gestation identified through linkage with national pregnancy registers.

Time frame
Up to 21 weeks and 6 days of gestation
2

Number of Participants With Preterm Birth Before 37 Completed Weeks of Gestation

Delivery before 37 completed weeks of gestation identified through national birth registers.

Time frame
At delivery
3

Number of Participants With Preeclampsia

Diagnosis of preeclampsia recorded in national health registers according to ICD codes.

Time frame
During pregnancy through 6 weeks postpartum
4

Relative Abundance of Prespecified Microbial Taxa in Female Reproductive Tract Samples

Relative abundance of prespecified microbial taxa measured in female reproductive tract samples collected at baseline using sequencing-based metagenomic profiling.

Time frame
Time Frame: Baseline (Day 0, prior to initiation of IVF stimulation); early pregnancy confirmation visit (gestational weeks 7 to 9); and at miscarriage, if applicable, during pregnancy up to gestational age 21 weeks 6 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.